BSE Prices delayed by 5 minutes ! Prices as on   May 07, 2025   

MARKETS

Company Info

CASH FLOW

Sun Pharmaceutical Industries Ltd.

You can view the cash flow for the last 5 years.
GO

BSE

May 07
1781.35 -37.40 ( -2.06%)
Volume 43082
Prev. Close 1818.75
Open Price 1800.05
Today's Low / High
1778.85
     
1825.00
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
1376.75
     
1960.20

NSE

May 07
1781.30 -37.80 ( -2.08%)
Volume 2015237
Prev. Close 1819.10
Open Price 1817.90
Today's Low / High
1778.70
     
1826.40
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
1377.20
     
1960.35
ISIN No INE044A01036 Market Cap. ( in Cr. ) 427393.54 P/BV 6.18 Book Value ( ) 288.06
BSE Code 524715 52 Week High/Low ( ) 1960/1377 FV/ML 1/1 P/E(X) 44.63
NSE Code SUNPHARMAEQ Book Closure 06/02/2025 EPS ( ) 39.91 Div Yield (%) 0.76
( in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
Net Profit/Loss Before Extraordinary Items And Tax11087.899408.434481.322799.375009.59
      
Net CashFlow From Operating Activities12134.984959.338984.546170.376554.77
Net Cash Used In Investing Activities-690.20-7943.68-5724.74536.22-2588.84
Net Cash Used From Financing Activities-6710.162376.07-5193.46-5980.48-5715.14
Foreign Exchange Gains / Losses-73.99157.07127.43-129.69363.52
Adjustments On Amalgamation / Merger / Demerger And Others1.29566.6941.450.000.00
      
Net Inc/Dec In Cash And Cash Equivalents4661.92115.48-1764.78596.42-1385.69
Cash And Cash Equivalents Begin of Year4623.734508.256273.035676.617062.30
Cash And Cash Equivalents End Of Year9285.654623.734508.256273.035676.61
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
Net Profit/Loss Before Extraordinary Items And Tax11087.89
Net CashFlow From Operating Activities12134.98
Net Cash Used In Investing Activities-690.20
Net Cash Used From Financing Activities-6710.16
Foreign Exchange Gains / Losses-73.99
Adjustments On Amalgamation / Merger / Demerger And Others1.29
Net Inc/Dec In Cash And Cash Equivalents4661.92
Cash And Cash Equivalents Begin of Year4623.73
Cash And Cash Equivalents End Of Year9285.65